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ABstract
Introduction: Influenza virus-associated encephalitis/encephalopathy is a severe childhood illness
with a poor prognosis. Adult case reports are rare and, to date, there have been no reports of
adults with a mild subcortical encephalopathy with reversible lesions of the corpus callosum
splenium.
Case presentation: A previously healthy 35-year-old man presented with acute progressive
tetraplegia, transcortical motor aphasia and a mild decrease in his consciousness during his
recovery after receiving oseltamivir phosphate treatment, and influenza type A antiviral medication.
The initial magnetic resonance imaging study at day 1 showed symmetrical diffuse lesions in the
white matter and a lesion on the central portion of the corpus callosum splenium. These findings
had resolved on follow-up studies at day 8 and day 146. His neurological deficits mostly recovered
within 12 hours following methylprednisolone pulse therapy. The levels of interleukin-6 and
interleukin-10 in his blood and cerebrospinal fluid were initially elevated, but rapidly decreased to
normal levels by day 8.
Conclusion: It is important for clinicians to recognize that even in adulthood, the subcortical
encephalopathy observed during the therapeutic treatment for influenza type A infection can occur
in conjunction with a reversible lesion of the corpus callosum, which may recover quickly. In
addition, the cytokine storm in the blood system and the corticospinal cavity may play an important
role in the etiology of the disease process.
Introduction
Influenza virus-associated encephalitis/encephalopathy
(IAEE) [1-4] is known to have a poor prognosis in child-
hood, especially in children under the age of 5 years. An
acute necrotizing encephalopathy, Reye's syndrome, hem-
orrhagic shock and encephalopathy are the most feared
and often fatal complications in IAEE [5,6]. Although
there has been a great improvement in therapeutic
approaches, the rates of mortality (31.8%) and disability
(27.7%) are still quite high. Recently, the number of
patients in Japan with childhood IAEE has increased [3,7],
although the number of adult case reports remains small.
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tory cytokine-related disease [8]. Cytokine levels in serum
and cerebrospinal fluid (CSF) are markedly increased in
the majority of severe IAEE cases, especially levels of inter-
leukin (IL)-6, IL-10 and soluble tumor necrosis factor
receptor 1. Therapeutically, anti-influenza treatments
such as a selective neuraminidase inhibitor (oseltamivir
phosphate), corticosteroid pulse and hypothermia are
quite effective in treating IAEE patients [9]. There are
reports demonstrating a variety of magnetic resonance
imaging (MRI) findings for IAEE, especially mild cases,
such as two children who recovered without any neuro-
logical deficit [10]. MRI for these children revealed a
lesion in the central portion of the corpus callosum sple-
nium, similar to that of the patient described in this
report. In addition, a recent review described such revers-
ible lesions caused by different pathoetiologies [11]. The
clinical features of these patients showed relatively mild
central nervous system (CNS) manifestations and com-
plete recovery within 1 month.
Here we report the case of an adult patient with mild IAEE,
who has recovered without any neurological deficit. The
complete follow-up study of MRI and the serum/CSF
cytokine assay are presented. MRI revealed a reversible
lesion of the central portion of the corpus callosum sple-
nium. Levels of IL-6 and IL-10 in his blood serum and the
IL-6 levels in his CSF were initially elevated and later
decreased to normal.
Case presentation
A previously healthy 35-year-old man contracted an influ-
enza type A virus infection. He had a high fever with a
mild painful throat, myalgia and arthralgia throughout
his whole body. He was diagnosed with an influenza type
A infection by a positive result from an influenza antigen
detection kit with a sample taken from a throat swab. He
started taking oseltamivir phosphate (three 75 mg cap-
sules) within 24 hours of the onset of high fever. The next
day, he had an acute progressive tetraplegia and transcor-
tical motor aphasia with mildly altered mental status. He
was then transferred to our emergency room for further
evaluation.
Initial MRI at day 1 (Figure 1a) showed lesions diffusely
throughout the white matter and especially on the central
portion of the corpus callosum splenium, with a slight
hyperintensity on T2-weighted fluid-attenuated inversion
recovery and markedly high signal intensity on diffusion-
weighted images. These findings resolved completely on
follow-up study at day 8 and day 146 (Figure 1b).
His cerebrospinal pressure was high (235 mmH2O), but
cytological and biochemical analyses of CSF were within
normal limits: number of cells was 3/3 mm3 (all mono-
cytes), protein level was 30.6 g/dl and the glucose level
was 67 mg/dl. The influenza genome was not detected by
polymerase chain reaction in CSF samples from day 1 and
day 8. Blood count showed a mild thrombocytopenia
(12.0 × 104 cells/ml) and leukopenia (2500 cells/ml).
Electroencephalography showed normal basic activity
with no paroxysmal discharge. He was treated with meth-
ylprednisolone pulse therapy (1000 mg/day) for 3 days;
his condition improved quickly following this treatment.
After a 2-week rehabilitation, he made a complete recov-
ery and was discharged from the hospital on day 24.
The levels of cytokines in his blood serum and CSF were
assayed at pre- and post-treatment with methylpred-
nisolone, as described previously [8]. In the blood serum,
IL-6 and IL-10 levels were elevated at day 1 (pre-treat-
ment) and had decreased to normal at day 8 (post-treat-
ment). In the CSF, IL-6 levels were remarkably high (19.6
pg/ml) at day 1 and had decreased to normal by day 8
(Table 1 and Figure 2). The levels of IL-6 and IL-10 in the
serum and CSF were correlated with his clinical course.
Discussion
Here, we have presented a case of adult IAEE with tran-
sient reversible CNS manifestations and MRI findings
revealing a reversible lesion of T2 prolongation and
reduced diffusion in the central portion of the corpus cal-
losum splenium. During the initial examination, our first
impression of this distinctive MRI finding was an acute
disseminated encephalomyelitis (ADEM), which was
foremost in our differential diagnosis. Corticosteroid
pulse therapy was undertaken and, upon initiation of
treatment, the MRI findings rapidly disappeared in con-
junction with clinical improvement, although the lesion
in the white matter recovered more slowly.
Recently, two cases of children with mild IAEE and with
similar MRI findings were reported [10]. These patients
developed symptoms soon after the onset of influenza
and also had rapid complete recoveries without any per-
manent functional deficit. The pathogenesis of the revers-
ible lesion in these cases is considered to be due to
transient intramyelinic edema. It is postulated that the
increased levels of pre-inflammatory cytokines such as IL-
6 [3,4,8] might play an important role in the pathogenesis
of the lesion. Our cytokine assay, which detected the ele-
vation of the IL-6 and IL-10 levels in our patient's blood
serum and CSF, supports this theory. An acute surge in
cytokine levels in the blood stream and CSF cavity might
trigger vasodilatation following a reversible vasogenic
edema of myelin. In addition, similar MRI findings in the
central splenium of the corpus callosum have been
reported [11] in some cases of infectious encephalitis or
encephalopathy other than IAEE, such as rotavirus [12],
O-157 Escherichia coli [13] and Salmonella enteritidis [14].Page 2 of 5
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Magnetic resonance imaging showed a transient signal in the central splenium of the corpus callosumFigure 1
Magnetic resonance imaging showed a transient signal in the central splenium of the corpus callosum. (a) Mag-
netic resonance imaging on day 1: T1-weighted images, fluid-attenuated inversion recovery images, T2-weighted images and dif-
fusion-weighted images. Fluid-attenuated inversion recovery images, T2-weighted images and diffusion-weighted images show 
lesions in the central splenium of the corpus callosum and symmetric bilateral white matter, but these were not observed in 
T1-weighted images. (b) The time course of magnetic resonance imaging shows that the lesions in the corpus callosum had 
resolved, with fluid-attenuated inversion recovery images and T2-weighted images at day 8. Magnetic resonance imaging on day 
146 showed that all of these lesions had almost completely disappeared.
Journal of Medical Case Reports 2008, 2:220 http://www.jmedicalcasereports.com/content/2/1/220Despite the different causative agents described in these
reports, the clinical manifestations and MRI findings were
nearly identical in these cases.
The possibility remains that the oseltamivir phosphate
could have aggravated his condition; this selective neu-
raminidase inhibitor might influence the development of
a pathological mechanism that results in vasogenic edema
followed by a cytokine storm. It may play a role in aggre-
gating influenza virus particles on the surface of blood
cells, endothelial cells or arachnoid cells. These aggregates
might then stimulate the release of pro-inflammatory
cytokines from these cells. However, we concluded that
early treatment with oseltamivir phosphate was still use-
ful in reducing some of his clinical symptoms, including
his high fever.
This case was diagnosed as a mild IAEE, and our clinical
examinations allowed us to discount other possibly diag-
Clinical course and cytokine levelsFigure 2
Clinical course and cytokine levels. Top, a clinical course of this case is shown. The patient had a high fever with mild pain-
ful throat, myalgia and arthralgia. Soon after taking three capsules (225 mg) of oseltamivir phosphate the fever reduced, but was 
then followed by dullness of consciousness, transcortical motor aphasia and tetraplegia, without sensory disturbance. During 
corticosteroid pulse therapy all of the neurological deficits disappeared. Bottom, a graph shows the time course of interleukin-
6 and interleukin-10 levels in his blood serum and cerebrospinal fluid.
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Table 1: Significantly increased interleukin-6 and interleukin-10 
levels in the cerebrospinal fluid
serum CSF
day 1 8 1 8
IL-6 7.9 4.2 20 3.5
IL-4 3.2 <2.6 <2.6 <2.6
IL-2 <2.6 <2.6 <2.6 <2.6
IFN-γ <7.1 <7.1 <7.1 <7.1
TNF-α 2.8 <2.8 <2.8 <2.8
IL-10 7.5 2.9 <2.8 <2.8
pg/ml
Cytokine assay study of blood serum and cerebrospinal fluid at the 
time points of pre- and post-treatment with methylprednisolone. In 
the patient's serum, interleukin-6 and interleukin-10 were elevated at 
day 1 (pre-treatment) and decreased at day 8 (post-treatment). In his 
cerebrospinal fluid, interleukin-6 levels were remarkably high (19.6 
pg/ml) at day 1 and reduced to normal levels by day 8.Page 4 of 5
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noses, including ADEM and other CNS disorders. The
cytokine storm in his blood system and corticospinal cav-
ity played an important role in the pathoetiology of the
IAEE.
Conclusion
We have reported a mild case of IAEE in an adult patient
with a transient neurological deficit and interesting revers-
ible lesions in the central splenium of the corpus callo-
sum. It is important for clinicians to recognize that, even
in adulthood, the subcortical encephalopathy observed
during therapy for influenza type A infection can occur in
conjunction with a reversible lesion of the corpus callo-
sum, which may recover quickly. In addition, the cytokine
storm in the blood system and the corticospinal cavity
may play an important role in the etiology of this disease
process.
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